PDCD1 and cancer: Malignant tumors often inhibit the natural immune responses via signal pathways of programmed death–ligand 1 (PD-L1), programmed cell death protein 1 (PD-1), or cytotoxic T-lymphocyte–associated protein 4 (CTLA-4).